These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16906593

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pulmonary alveolar proteinosis].
    Floarea-Strat A, Stanciu A, Creţeanu M.
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):518-23. PubMed ID: 14756054
    [Abstract] [Full Text] [Related]

  • 4. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.
    Latzin P, Tredano M, Wüst Y, de Blic J, Nicolai T, Bewig B, Stanzel F, Köhler D, Bahuau M, Griese M.
    Thorax; 2005 Jan; 60(1):39-44. PubMed ID: 15618581
    [Abstract] [Full Text] [Related]

  • 5. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL, Swaisgood CM, Barna BP, Farver CF, Kavuru MS, Thomassen MJ.
    J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
    [Abstract] [Full Text] [Related]

  • 6. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF, Chen Y, Guo ZJ, Zhu YJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary alveolar proteinosis.
    Khan A, Agarwal R.
    Respir Care; 2011 Jul; 56(7):1016-28. PubMed ID: 21496372
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary alveolar proteinosis.
    Wang T, Lazar CA, Fishbein MC, Lynch JP.
    Semin Respir Crit Care Med; 2012 Oct; 33(5):498-508. PubMed ID: 23001804
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
    Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS.
    Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
    [Abstract] [Full Text] [Related]

  • 10. Pulmonary alveolar proteinosis during a 30-year observation. Diagnosis and treatment.
    Fijołek J, Wiatr E, Radzikowska E, Bestry I, Langfort R, Polubiec-Kownacka M, Prokopowicz J, Roszkowski-Śliż K.
    Pneumonol Alergol Pol; 2014 May; 82(3):206-17. PubMed ID: 24793148
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary alveolar proteinosis in pediatric leukemia.
    Inaba H, Jenkins JJ, McCarville MB, Morrison RR, Howard SC, Pui CH, Ribeiro RC.
    Pediatr Blood Cancer; 2008 Jul; 51(1):66-70. PubMed ID: 18085671
    [Abstract] [Full Text] [Related]

  • 12. A case of idiopathic pulmonary alveolar proteinosis accompanied by T-cell receptor gene rearrangement in bronchoalveolar lavage fluid cells.
    Hosokawa T, Yamaguchi E, Shirai S, Fuke S, Takaoka K, Kojima J, Nakata K, Nishimura M.
    Respirology; 2004 Jun; 9(2):286-8. PubMed ID: 15182285
    [Abstract] [Full Text] [Related]

  • 13. Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.
    Yamasue M, Nureki SI, Usagawa Y, Ono T, Matsumoto H, Kan T, Kadota JI.
    Tohoku J Exp Med; 2017 Sep; 243(1):77-83. PubMed ID: 28966213
    [Abstract] [Full Text] [Related]

  • 14. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
    Bonfield TL, John N, Malur A, Barna BP, Culver DA, Kavuru MS, Thomassen MJ.
    Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary alveolar proteinosis: time to shift?
    Papiris SA, Tsirigotis P, Kolilekas L, Papadaki G, Papaioannou AI, Triantafillidou C, Papaporfyriou A, Karakatsani A, Kagouridis K, Griese M, Manali ED.
    Expert Rev Respir Med; 2015 Jun; 9(3):337-49. PubMed ID: 25864717
    [Abstract] [Full Text] [Related]

  • 16. Experience with treatment of pulmonary alveolar proteinosis from a tertiary care centre in north India.
    Khan A, Agarwal R, Aggarwal AN, Bal A, Sen I, Yaddanapuddi LN, Puri GD.
    Indian J Chest Dis Allied Sci; 2012 Jun; 54(2):91-7. PubMed ID: 22973777
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.
    Lin FC, Chang GD, Chern MS, Chen YC, Chang SC.
    Thorax; 2006 Jun; 61(6):528-34. PubMed ID: 16517574
    [Abstract] [Full Text] [Related]

  • 18. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis.
    Yamamoto H, Yamaguchi E, Agata H, Kandatsu N, Komatsu T, Kawai S, Baba K, Awaya T, Nishikomori R, Tsurusawa M, Nakata K.
    Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary Alveolar Proteinosis: recent advances.
    Mazzone PJ, Jane Thomassen M, Kavuru MS.
    Semin Respir Crit Care Med; 2002 Apr; 23(2):115-26. PubMed ID: 16088604
    [Abstract] [Full Text] [Related]

  • 20. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA, Rodríguez Becerra E, Sánchez Garrido A.
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.